Access Innovation BioBridge
About
BioBridge is a 6–10 month pilot program that helps clinical-stage life science companies expand into new markets through the Access Consortium, a coalition of five trusted regulatory authorities.
The program connects companies with regulatory guidance, validation infrastructure, strategic partners, and investors in their target market. The pilot phase opens a Canada-to-UK corridor, with additional corridors to follow.
What is your business/industry sector?
Biotech, Pharma and CosmeticsHealthcare